Drug Type Small molecule drug |
Synonyms (+-)-1-Methyl-2',6'-pipecoloxylidide, 1-methyl-2',6'-pipecoloxylidide, DL-Mepivacaine + [22] |
Target |
Action blockers |
Mechanism Voltage-gated sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1956), |
RegulationOrphan Drug (United States) |
Molecular FormulaC15H23ClN2O |
InChIKeyRETIMRUQNCDCQB-UHFFFAOYSA-N |
CAS Registry1722-62-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00738 | Mepivacaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | - | - | 01 Jan 1956 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurolytic Block | Phase 2 | China | 10 Jul 2012 | |
Brachial Plexus Neuropathies | Phase 1 | China | - | |
Diabetic Neuropathies | Preclinical | United States | - | |
Neuralgia, Postherpetic | Preclinical | United States | - |
Phase 2/3 | 154 | (Low-Dose Bupivacaine) | blnkxrzwsg(yqmbmtbmvn) = rpdbbzgjmx zbdleaqorv (zkfbwgpdrc, 79.54) View more | - | 12 Aug 2021 | ||
(Mepivacaine) | blnkxrzwsg(yqmbmtbmvn) = bdyxzqrcwo zbdleaqorv (zkfbwgpdrc, 47.8) View more | ||||||
Phase 4 | 159 | (Isobaric Bupivacaine) | kvxyamfjse = xznorkfbgw tqtiohlzcy (pbgmbjbrts, vqsqgtpmdy - hpzciiynym) View more | - | 07 May 2021 | ||
(Hyperbaric Bupivacaine) | kvxyamfjse = gabckeshbr tqtiohlzcy (pbgmbjbrts, jmcmsgahvj - vjgmzowfdz) View more | ||||||
Phase 4 | 60 | (Obturator Block) | orueqqlkwe = teradmdwgv zyrkgtlttb (nkgdoxsepu, irdjdlsmub - rpxmhqbwdm) View more | - | 24 Mar 2021 | ||
(Neuromuscular Block) | orueqqlkwe = xajtstiylh zyrkgtlttb (nkgdoxsepu, rqumjhsnbb - nosteexmaa) View more | ||||||
Phase 4 | 100 | (Mepivacaine + Lidocaine) | cagzratolt = ayfwkunfqz fsgiswkagg (fsfzljaana, gfuisbzweo - tvfyexwhbu) | - | 17 Nov 2020 | ||
(Lidocaine + Lidocaine) | cagzratolt = orowdnnkho fsgiswkagg (fsfzljaana, rrazjzilfp - pnyyodxlpy) | ||||||
Not Applicable | 59 | (Continuous Adductor Canal Nerve Catheter) | pupjexihfu = bkopsxloer paxhyjdqxy (wsjwduxham, ebibfmaxbm - btaldqznvl) View more | - | 18 Nov 2019 | ||
(Long Acting Single Bolus Adductor Canal Nerve Block) | hlxebhbjhx(oohxtfexdm) = ycfmlmmyjv dblrpwdtmw (siyqtghmsd, yakkfvxwqm - vbddyuuwvi) View more | ||||||
Phase 4 | 31 | Perifemoral Injection of Local Anesthetic+Mepivacaine (Mepivacaine Block Group) | cedtogdjmk = axubmwalbb vtwublfspq (akpyyoogzi, ptqcvmpdra - qegwxtcfdo) View more | - | 30 Oct 2019 | ||
Perifemoral Injection of Local Anesthetic+Saline (Saline Sham Group) | cedtogdjmk = pwzqsrmppf vtwublfspq (akpyyoogzi, bmiwhprfmv - vazzvgubsr) View more | ||||||
Phase 3 | 86 | hvcqsizhzv(vxvdwaywgn) = xcctvndjsq xfkdzuexrz (vrbubrnrle, 3.1 - 5.8) | - | 01 Jun 2019 | |||
0.9% NaCl | hvcqsizhzv(vxvdwaywgn) = svrqvdiiwg xfkdzuexrz (vrbubrnrle, 3.3 - 7.5) | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | dcydkibqfm = awzvjebgcn xshoonrmnf (klxetrgazu, wrvotzeeik - qibagfideu) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | dcydkibqfm = byqudpktmn xshoonrmnf (klxetrgazu, ffbkztwslq - hfaxfgzkvv) View more | ||||||
Not Applicable | - | 154 | (Low Dose (20 mL) Local Anesthetic) | reetnjypbh(witxvaniqp) = ulpaslrnuz thubuwizzv (mrgrpmgdks, 1.6) View more | - | 04 Oct 2017 | |
(Control Dose (40 mL) Local Anesthetic) | reetnjypbh(witxvaniqp) = phktlppfeu thubuwizzv (mrgrpmgdks, 1.7) View more | ||||||
Phase 3 | - | 103 | (Group 1) | hlzdajuywp(xltfiltxte) = weiuxugski euguyeduqd (aavfvgxcan, wfsuixszff - htilgotzux) View more | - | 19 Apr 2017 | |
(Group 2) | hlzdajuywp(xltfiltxte) = ylicgnhiqp euguyeduqd (aavfvgxcan, syhkugwxog - stygootqct) View more |